[15 May 2013]
Products Affected - Description
Estradiol tablets, Mylan
0.5 mg, 100 count bottles (NDC 00378-1452-01)
0.5 mg, 500 count bottles (NDC 00378-1452-05)
1 mg, 100 count bottles (NDC 00378-1454-01)
1 mg, 500 count bottles (NDC 00378-1454-05)
2 mg, 100 count bottles (NDC 00378-1458-01)
2 mg, 500 count bottles (NDC 00378-1458-05)
Estradiol tablets, Teva
0.5 mg, 100 count bottles (NDC 00555-0899-02)
1 mg, 100 count bottles (NDC 00555-0886-02)
1 mg, 500 count bottles (NDC 00555-0886-04)
2 mg, 500 count bottles (NDC 00555-0887-04)
Estradiol tablets, Watson
0.5 mg, 100 count bottles (NDC 00591-0528-01)
1 mg, 100 count bottles (NDC 00591-0487-01)
1 mg, 500 count bottles (NDC 00591-0487-05)
2 mg, 100 count bottles (NDC 00591-0488-01)
2 mg, 500 count bottles (NDC 00591-0488-05)
Estrace, Warner Chilcott
1 mg, 100 count bottles (NDC 00430-0721-24)
Reason for the Shortage
- Mylan could not provide a reason for the shortage.
- Teva could not provide a reason for the shortage.
- Watson stated the shortage was due to production delays.
Available Products
Estradiol tablets, Mylan
2 mg, 90 count bottles (NDC 00378-1458-77)
Estradiol tablets, Teva
2 mg, 100 count bottles (NDC 00555-0887-02)
Estrace, Warner Chilcott
0.5 mg, 100 count bottles (NDC 00430-0720-24)
2 mg, 100 count bottles (NDC 00430-0722-24)
Estimated Resupply Dates
- Mylan has estradiol 0.5 mg tablets in 100 count on back order and the company estimates a release date in late-May 2013. All other estradiol presentations are on back order and the company cannot estimate a release date.
- Teva has all estradiol tablets on back order and the company estimates a release date of late-May, 2013.
- Watson has all presentations of estradiol tablets on allocation.
- Warner Chilcott has Estrace 1 mg tablets on back order and the company cannot estimate a release date.
Related Shortages
Updated
May 15, 2013; May 10, 2013; April 23, 2013; March 25, 2013; March 20, 2013; March 7, 2013; February 6, 2013; January 23, 2013; January 2, 2013; December 21, 2012; December 7, 2012; November 12, 2012; November 2, 2012; October 10, 2012; September 25, 2012. University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins